Skip to content

The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies

The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01384136
Enrollment
100
Registered
2011-06-28
Start date
2011-06-30
Completion date
2015-06-30
Last updated
2011-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Risk Pregnancies, Mechanisms of Telomter Homeostasis, Telomere Length

Brief summary

The telomere system stabilizes the chromosomes. Telomeres are shortened during senescence, in cases of genetic instability and secondary to stress. The investigators aim is to study the telomere system in cord blood and in the placenta immediately after the delivery in pregnancies defined as high risk pregnancies following sterss events such as placental insufficiency, preeclampsia, diabetes. The investigators intend to compare the telomere system in maternal blood to cord blood and to placental biopsies and to study the influence of different stressogenes on this system.

Interventions

None listed

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Third trimester post delivery * Intrauterine growth restriction * Preeclampsia * Diabetes * Control - low risk normal pregnancies

Exclusion criteria

* Patients who do not want to participate * Known HIV or Hepatitis

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026